Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Jul-24 4:05 PM View:  | Kemble George Executive Chairman Director | Sagimet Biosciences Inc. (SGMT) | 23-Jul-24 | Sale (Planned) | 23,625 | $3.17 | $74,829.80 | (17%) 142.32K to 118.69K | |
| 23-Jul-24 4:05 PM View: | Rozek Elizabeth General Counsel and CCO | Sagimet Biosciences Inc. (SGMT) | 19-Jul-24 | Sale | 10,914 | $3.10 | $33,830.10 | (6%) 171.42K to 160.51K | |
| 23-Jul-24 4:06 PM View: | Martins Eduardo Bruno Chief Medical Officer | Sagimet Biosciences Inc. (SGMT) | 19-Jul-24 | Sale | 8,357 | $3.10 | $25,910.00 | (9%) 89.57K to 81.21K | |
| 23-Jul-24 4:05 PM View: | Kemble George Executive Chairman Director | Sagimet Biosciences Inc. (SGMT) | 19-Jul-24 | Sale | 14,062 | $3.10 | $43,604.90 | (9%) 156.38K to 142.32K | |
| 28-Mar-24 4:08 PM View: | Happel David President & CEO Director | Sagimet Biosciences Inc. (SGMT) | 26-Mar-24 | Purchase | 12,100 | $5.27 | $63,730.70 | 2% 627.1K to 639.2K | |
| 31-Jan-24 5:00 PM View: | Sandell Scott D 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Disposition (other) Duplicate | 1,110,950 | -- | -- | (27%) 4.12M to 3.01M | |
| 31-Jan-24 4:56 PM View: | Nea Partners 13, Limited Pa... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Disposition (other) Duplicate | 850,000 | -- | -- | (21%) 4.11M to 3.26M | |
| 31-Jan-24 4:57 PM View: | Baskett Forest 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Disposition (other) | 1,110,950 | -- | -- | (27%) 4.12M to 3.01M | |
| 31-Jan-24 4:59 PM View: | Kerins Patrick J 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Disposition (other) Duplicate | 1,110,950 | -- | -- | (27%) 4.12M to 3.01M | |
| 31-Jan-24 4:55 PM View: | New Enterprise Associates 1... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Disposition (other) | 850,000 | -- | -- | (22%) 3.85M to 3.0M | |
| 31-Jan-24 4:56 PM View: | Nea Partners 13, Limited Pa... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Disposition (other) | 260,950 | -- | -- | (8%) 3.26M to 3.0M | |
| 31-Jan-24 4:59 PM View: | Kerins Patrick J 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Acquisition (other) Duplicate | 260,950 | -- | -- | 7% 3.85M to 4.11M | |
| 31-Jan-24 5:00 PM View: | Sandell Scott D 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Acquisition (other) | 267,947 | -- | -- | 7% 3.85M to 4.12M | |
| 31-Jan-24 4:56 PM View: | Nea Partners 13, Limited Pa... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Acquisition (other) | 260,950 | -- | -- | 7% 3.85M to 4.11M | |
| 31-Jan-24 4:57 PM View: | Baskett Forest 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Acquisition (other) | 272,250 | -- | -- | 7% 3.85M to 4.12M | |
| 31-Jan-24 4:59 PM View: | Kerins Patrick J 10% Owner | Sagimet Biosciences Inc. (SGMT) | 29-Jan-24 | Acquisition (other) | 13,139 | -- | -- | < 1% 4.11M to 4.12M | |
| 08-Dec-23 4:05 PM View: | Happel David President & CEO Director | Sagimet Biosciences Inc. (SGMT) | 07-Dec-23 | Purchase | 1,600 | $4.10 | $6,560.00 | < 1% 625.5K to 627.1K | |
| 21-Nov-23 4:21 PM View: | Happel David President & CEO Director | Sagimet Biosciences Inc. (SGMT) | 17-Nov-23 | Grant | 624,910 | -- | -- | 105917% 0.59K to 625.5K | |
| 21-Nov-23 10:00 PM View: | Rozek Elizabeth General Counsel and CCO | Sagimet Biosciences Inc. (SGMT) | 17-Nov-23 | Grant | 171,420 | -- | -- | 100% 0 to 171.42K | |
| 21-Nov-23 10:00 PM View: | Martins Eduardo Bruno Chief Medical Officer | Sagimet Biosciences Inc. (SGMT) | 17-Nov-23 | Grant | 89,570 | -- | -- | 100% 0 to 89.57K | |
| 21-Nov-23 4:22 PM View: | Kemble George Executive Chairman Director | Sagimet Biosciences Inc. (SGMT) | 17-Nov-23 | Grant | 150,750 | -- | -- | 2678% 5.63K to 156.38K | |
| 20-Nov-23 10:00 PM View: | Happel David President & CEO Director | Sagimet Biosciences Inc. (SGMT) | 16-Nov-23 | Purchase | 590 | $2.35 | $1,386.50 | 100% 0 to 0.59K | |
| 08-Sep-23 4:15 PM View: | Kemble George Executive Chairman Director | Sagimet Biosciences Inc. (SGMT) | 07-Sep-23 | Option Exercise | 5,630 | $0.79 | $4,447.70 | 100% 0 to 5.63K | |
| 20-Jul-23 4:20 PM View: | Seidenberg Beth C Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Conversion | 1,860,710 | -- | -- | 2400% 77.53K to 1.94M | |
| 20-Jul-23 4:20 PM View: | Seidenberg Beth C Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Purchase | 46,875 | $16.00 | $750,000.00 | 2% 2.02M to 2.07M | |
| 20-Jul-23 4:20 PM View: | Kpcb Pbd Associates, LLC 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Disposition (other) | 38,763 | -- | -- | (2%) 1.94M to 1.9M | |
| 20-Jul-23 6:56 PM View: | New Enterprise Associates 1... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Disposition (other) | 37,676 | -- | -- | (< 1%) 3.89M to 3.85M | |
| 20-Jul-23 6:56 PM View: | New Enterprise Associates 1... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Exercise (in-the money or at-the-money) | 13,404 | $0.79 | $10,653.50 | < 1% 3.88M to 3.89M | |
| 20-Jul-23 4:17 PM View: | Parsey Merdad Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Disposition | 8,677 | -- | -- | (40%) 21.47K to 12.79K | |
| 20-Jul-23 4:19 PM View: | Wu Jinzi Jason Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Conversion | 1,654,700 | -- | -- | 100% 0 to 1.65M | |
| 20-Jul-23 4:20 PM View: | Seidenberg Beth C Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Conversion | 84,768 | -- | -- | 4% 1.94M to 2.02M | |
| 20-Jul-23 4:20 PM View: | Kpcb Pbd Associates, LLC 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Conversion Duplicate | 1,860,710 | -- | -- | 4800% 38.77K to 1.9M | |
| 20-Jul-23 6:56 PM View: | New Enterprise Associates 1... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Conversion | 3,769,860 | -- | -- | 10006% 37.67K to 3.81M | |
| 20-Jul-23 6:56 PM View: | New Enterprise Associates 1... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Purchase | 30,000 | $16.00 | $480,000.00 | < 1% 3.85M to 3.88M | |
| 20-Jul-23 4:17 PM View: | Parsey Merdad Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Grant | 8,677 | -- | -- | 100% 8.68K to 17.35K | |
| 20-Jul-23 4:20 PM View: | Seidenberg Beth C Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Grant | 38,763 | -- | -- | 100% 38.76K to 77.53K | |
| 20-Jul-23 4:20 PM View: | Seidenberg Beth C Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Disposition | 38,763 | -- | -- | (2%) 2.07M to 2.03M | |
| 20-Jul-23 4:20 PM View: | Kpcb Pbd Associates, LLC 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Acquisition (other) | 38,763 | -- | -- | 2% 1.9M to 1.94M | |
| 20-Jul-23 6:56 PM View: | New Enterprise Associates 1... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Acquisition (other) | 37,676 | -- | -- | < 1% 3.81M to 3.85M | |
| 20-Jul-23 6:56 PM View: | New Enterprise Associates 1... 10% Owner | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Sale | 662 | $16.00 | $10,592.00 | (< 1%) 3.85M to 3.85M | |
| 20-Jul-23 4:17 PM View: | Parsey Merdad Director | Sagimet Biosciences Inc. (SGMT) | 18-Jul-23 | Conversion | 4,117 | -- | -- | 24% 17.35K to 21.47K |
